BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 26912071)

  • 1. Smac mimetic sensitizes renal cell carcinoma cells to interferon-α-induced apoptosis.
    Reiter M; Eckhardt I; Haferkamp A; Fulda S
    Cancer Lett; 2016 May; 375(1):1-8. PubMed ID: 26912071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smac mimetic triggers necroptosis in pancreatic carcinoma cells when caspase activation is blocked.
    Hannes S; Abhari BA; Fulda S
    Cancer Lett; 2016 Sep; 380(1):31-8. PubMed ID: 27267809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cooperative TRAIL production mediates IFNα/Smac mimetic-induced cell death in TNFα-resistant solid cancer cells.
    Roesler S; Eckhardt I; Wolf S; Fulda S
    Oncotarget; 2016 Jan; 7(4):3709-25. PubMed ID: 26788912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cotreatment with Smac mimetics and demethylating agents induces both apoptotic and necroptotic cell death pathways in acute lymphoblastic leukemia cells.
    Gerges S; Rohde K; Fulda S
    Cancer Lett; 2016 May; 375(1):127-132. PubMed ID: 26944210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smac mimetic primes apoptosis-resistant acute myeloid leukaemia cells for cytarabine-induced cell death by triggering necroptosis.
    Chromik J; Safferthal C; Serve H; Fulda S
    Cancer Lett; 2014 Mar; 344(1):101-109. PubMed ID: 24184825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a novel synergistic induction of cell death by Smac mimetic and HDAC inhibitors in acute myeloid leukemia cells.
    Steinwascher S; Nugues AL; Schoeneberger H; Fulda S
    Cancer Lett; 2015 Sep; 366(1):32-43. PubMed ID: 26028172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smac mimetic and oleanolic acid synergize to induce cell death in human hepatocellular carcinoma cells.
    Liese J; Abhari BA; Fulda S
    Cancer Lett; 2015 Aug; 365(1):47-56. PubMed ID: 25917078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential role of RIP1 in Smac mimetic-mediated chemosensitization of neuroblastoma cells.
    Czaplinski S; Abhari BA; Torkov A; Seggewiß D; Hugle M; Fulda S
    Oncotarget; 2015 Dec; 6(39):41522-34. PubMed ID: 26575016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic interaction of Smac mimetic and IFNα to trigger apoptosis in acute myeloid leukemia cells.
    Bake V; Roesler S; Eckhardt I; Belz K; Fulda S
    Cancer Lett; 2014 Dec; 355(2):224-31. PubMed ID: 25179908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smac mimetic sensitizes glioblastoma cells to Temozolomide-induced apoptosis in a RIP1- and NF-κB-dependent manner.
    Wagner L; Marschall V; Karl S; Cristofanon S; Zobel K; Deshayes K; Vucic D; Debatin KM; Fulda S
    Oncogene; 2013 Feb; 32(8):988-97. PubMed ID: 22469979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smac mimetics and type II interferon synergistically induce necroptosis in various cancer cell lines.
    Cekay MJ; Roesler S; Frank T; Knuth AK; Eckhardt I; Fulda S
    Cancer Lett; 2017 Dec; 410():228-237. PubMed ID: 28923396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of RIP1 as a critical mediator of Smac mimetic-mediated sensitization of glioblastoma cells for Drozitumab-induced apoptosis.
    Cristofanon S; Abhari BA; Krueger M; Tchoghandjian A; Momma S; Calaminus C; Vucic D; Pichler BJ; Fulda S
    Cell Death Dis; 2015 Apr; 6(4):e1724. PubMed ID: 25880091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting inhibitor of apoptosis proteins by Smac mimetic elicits cell death in poor prognostic subgroups of chronic lymphocytic leukemia.
    Opel D; Schnaiter A; Dodier D; Jovanovic M; Gerhardinger A; Idler I; Mertens D; Bullinger L; Stilgenbauer S; Fulda S
    Int J Cancer; 2015 Dec; 137(12):2959-70. PubMed ID: 26096065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RIP1 is required for IAP inhibitor-mediated sensitization for TRAIL-induced apoptosis via a RIP1/FADD/caspase-8 cell death complex.
    Abhari BA; Cristofanon S; Kappler R; von Schweinitz D; Humphreys R; Fulda S
    Oncogene; 2013 Jul; 32(27):3263-73. PubMed ID: 22890322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a synergistic combination of Smac mimetic and Bortezomib to trigger cell death in B-cell non-Hodgkin lymphoma cells.
    Bhatti IA; Abhari BA; Fulda S
    Cancer Lett; 2017 Oct; 405():63-72. PubMed ID: 28716527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smac mimetic and demethylating agents synergistically trigger cell death in acute myeloid leukemia cells and overcome apoptosis resistance by inducing necroptosis.
    Steinhart L; Belz K; Fulda S
    Cell Death Dis; 2013 Sep; 4(9):e802. PubMed ID: 24030154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smac mimetic bypasses apoptosis resistance in FADD- or caspase-8-deficient cells by priming for tumor necrosis factor α-induced necroptosis.
    Laukens B; Jennewein C; Schenk B; Vanlangenakker N; Schier A; Cristofanon S; Zobel K; Deshayes K; Vucic D; Jeremias I; Bertrand MJ; Vandenabeele P; Fulda S
    Neoplasia; 2011 Oct; 13(10):971-9. PubMed ID: 22028622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteasome inhibitors and Smac mimetics cooperate to induce cell death in diffuse large B-cell lymphoma by stabilizing NOXA and triggering mitochondrial apoptosis.
    Dietz A; Dalda N; Zielke S; Dittmann J; van Wijk SJL; Vogler M; Fulda S
    Int J Cancer; 2020 Sep; 147(5):1485-1498. PubMed ID: 32170726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic targeting of necroptosis by Smac mimetic bypasses apoptosis resistance in acute myeloid leukemia cells.
    Safferthal C; Rohde K; Fulda S
    Oncogene; 2017 Mar; 36(11):1487-1502. PubMed ID: 27869161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smac mimetic and glucocorticoids synergize to induce apoptosis in childhood ALL by promoting ripoptosome assembly.
    Belz K; Schoeneberger H; Wehner S; Weigert A; Bönig H; Klingebiel T; Fichtner I; Fulda S
    Blood; 2014 Jul; 124(2):240-50. PubMed ID: 24855207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.